Nivolumab vs Semaglutide

## Nivolumab vs Semaglutide: Overview

This comparison examines the pharmacological differences between **Nivolumab** and **Semaglutide**.

## Mechanism of Action

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

**Semaglutide**: GLP-1 receptor agonist with enhanced albumin binding for extended action.

## Pharmacokinetics

**Half-life**: Nivolumab — 27 days; Semaglutide — 7 days.

## Chemical Properties

**Type**: Nivolumab — Antibody; Semaglutide — Protein.